1. Home
  2. GKOS vs SIRI Comparison

GKOS vs SIRI Comparison

Compare GKOS & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$103.96

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Logo Sirius XM Holdings Inc.

SIRI

Sirius XM Holdings Inc.

N/A

Current Price

$22.32

Market Cap

7.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
SIRI
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
7.3B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
GKOS
SIRI
Price
$103.96
$22.32
Analyst Decision
Strong Buy
Hold
Analyst Count
14
8
Target Price
$133.07
$25.00
AVG Volume (30 Days)
662.2K
3.7M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
4.96%
EPS Growth
N/A
136.32
EPS
N/A
2.23
Revenue
$507,442,000.00
$5,425,129,000.00
Revenue This Year
$23.39
$1.81
Revenue Next Year
$27.46
$0.65
P/E Ratio
N/A
$9.76
Revenue Growth
32.33
8.13
52 Week Low
$73.16
$18.69
52 Week High
$130.23
$24.55

Technical Indicators

Market Signals
Indicator
GKOS
SIRI
Relative Strength Index (RSI) 35.28 59.01
Support Level $81.54 $22.02
Resistance Level $106.52 $22.46
Average True Range (ATR) 3.58 0.52
MACD -1.81 0.04
Stochastic Oscillator 14.28 73.29

Price Performance

Historical Comparison
GKOS
SIRI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SIRI Sirius XM Holdings Inc.

SiriusXM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates, and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.

Share on Social Networks: